Literature DB >> 13129585

Design, synthesis, and biological evaluation of simplified alpha-keto heterocycle, trifluoromethyl ketone, and formyl substituted folate analogues as potential inhibitors of GAR transformylase and AICAR transformylase.

Thomas H Marsilje1, Michael P Hedrick, Joel Desharnais, Ali Tavassoli, Yan Zhang, Ian A Wilson, Stephen J Benkovic, Dale L Boger.   

Abstract

A series of simplified alpha-keto heterocycle, trifluoromethyl ketone, and formyl substituted folate analogues lacking the benzoylglutamate subunit were prepared and examined as potential inhibitors of glycinamide ribonucleotide transformylase (GAR Tfase) and aminoimidazole carboxamide transformylase (AICAR Tfase).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129585     DOI: 10.1016/s0968-0896(03)00456-5

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies.

Authors:  Christina M Rodrigo; Regina Cencic; Stéphane P Roche; Jerry Pelletier; John A Porco
Journal:  J Med Chem       Date:  2011-12-19       Impact factor: 7.446

2.  Human glycinamide ribonucleotide transformylase: active site mutants as mechanistic probes.

Authors:  Wanda Manieri; Molly E Moore; Matthew B Soellner; Pearl Tsang; Carol A Caperelli
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

3.  Biological and structural evaluation of 10R- and 10S-methylthio-DDACTHF reveals a new role for sulfur in inhibition of glycinamide ribonucleotide transformylase.

Authors:  Stephen Connelly; Jessica K DeMartino; Dale L Boger; Ian A Wilson
Journal:  Biochemistry       Date:  2013-07-19       Impact factor: 3.162

4.  Targeting tumour proliferation with a small-molecule inhibitor of AICAR transformylase homodimerization.

Authors:  Ian B Spurr; Charles N Birts; Francesco Cuda; Stephen J Benkovic; Jeremy P Blaydes; Ali Tavassoli
Journal:  Chembiochem       Date:  2012-07-04       Impact factor: 3.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.